Skip to main content
. 2019 Jan 8;10(3):383–394. doi: 10.18632/oncotarget.26555

Table 2. sAPE1 level and its association with clinical and pathological characteristics of the HCC group.

sAPE1 (pg/mL)
Count Median (95% CI) p value
Age ns
<72 52 74.2 (60.5–96.4)
>72 47 78.8 (66.2–103.7)
Sex ns
Male 77 73.9 (63.2–87.2)
Female 22 97.1 (65.0–122.9)
Etiology <0.001
Alcohol metabolic 54 62.6 (48.6–73.9)
Alcohol metabolic viral 18 132.37 (84.3–208.2)
Viral 23 98.8 (85.4–141.1)
Other* 4 63.2
CTP ns
A 73 78.8 (65.0–96.4)
B/C 23 70.76 (44.5–128.6)
BCLC ns
0-A 65 77.3 (60.5–96.4)
B-C-D 32 74.5 (48.6–101.3)
GRETCH <0.05
Low 15 60.5 (33.0–101.3)
Intermediate-high 68 83.2 (68.1–91.1)
CLIP ns
0–1 59 78.7 (67.3–97.7)
2–3–4 25 71.6 (56.1–114.7)
ITA.LI.CA prognostic ns
2 44 87.1 (69.7–107.8)
3 21 74.6 (56.1–108.7)
4 12 53.5 (32.3–159.2)
5–8 7 71.6 (40.3–138.3)
Number of lesions ns
Single <2 cm 15 86.9 (43.8–120.4)
Single or 3 <3 cm 46 74.6 (60.5–117.9)
Large-single or multi 37 74.5 (61.2–89.5)
AFP ns
<20 ng/mL 52 76.7 (65–87.2)
20–400 ng/mL 13 138.3 (37.1–179.9)
>400 ng/mL 12 80.5 (43.8–122.9)